Envestnet Asset Management Inc Ironwood Pharmaceuticals Inc Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q4 2024

A detailed history of Envestnet Asset Management Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 11,272 shares of IRWD stock, worth $20,289. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,272
Holding current value
$20,289
% of portfolio
0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$3.34 - $5.04 $37,648 - $56,810
11,272 New
11,272 $49,000
Q2 2024

Aug 08, 2024
BUY
$5.58 - $8.61 $12,404 - $19,140
2,223 Added 13.3%
18,935 $123,000
Q1 2024

May 13, 2024
BUY
$8.32 - $15.45 $48,963 - $90,923
5,885 Added 54.35%
16,712 $145,000
Q4 2023

Feb 13, 2024
SELL
$8.79 - $11.51 $1,441 - $1,887
-164 Reduced 1.49%
10,827 $123,000
Q3 2023

Nov 13, 2023
SELL
$8.25 - $11.35 $1.93 Million - $2.66 Million
-233,928 Reduced 95.51%
10,991 $105,000
Q2 2023

Aug 04, 2023
SELL
$10.1 - $11.6 $2.64 Million - $3.03 Million
-261,035 Reduced 51.59%
244,919 $2.61 Million
Q1 2023

May 11, 2023
BUY
$10.37 - $12.56 $2.92 Million - $3.54 Million
281,820 Added 125.74%
505,954 $5.32 Million
Q4 2022

Feb 07, 2023
BUY
$9.9 - $12.43 $96,802 - $121,540
9,778 Added 4.56%
224,134 $2.78 Million
Q3 2022

Nov 10, 2022
SELL
$10.14 - $12.38 $35,064 - $42,810
-3,458 Reduced 1.59%
214,356 $2.22 Million
Q2 2022

Aug 03, 2022
BUY
$11.05 - $12.72 $234,315 - $269,727
21,205 Added 10.79%
217,814 $2.51 Million
Q1 2022

May 04, 2022
BUY
$10.61 - $12.88 $452,049 - $548,765
42,606 Added 27.67%
196,609 $2.47 Million
Q4 2021

Feb 04, 2022
BUY
$10.86 - $13.95 $914,574 - $1.17 Million
84,215 Added 120.67%
154,003 $1.8 Million
Q3 2021

Oct 07, 2021
BUY
$11.92 - $13.92 $181,303 - $211,723
15,210 Added 27.87%
69,788 $911,000
Q2 2021

Aug 04, 2021
BUY
$10.16 - $13.11 $30,805 - $39,749
3,032 Added 5.88%
54,578 $702,000
Q1 2021

May 04, 2021
SELL
$9.04 - $11.86 $1,563 - $2,051
-173 Reduced 0.33%
51,546 $576,000
Q4 2020

Feb 02, 2021
BUY
$9.05 - $12.2 $98,581 - $132,894
10,893 Added 26.68%
51,719 $589,000
Q3 2020

Oct 09, 2020
SELL
$8.99 - $10.74 $511,081 - $610,569
-56,850 Reduced 58.2%
40,826 $367,000
Q2 2020

Jul 08, 2020
BUY
$9.14 - $11.97 $424,936 - $556,509
46,492 Added 90.83%
97,676 $1.01 Million
Q1 2020

Apr 23, 2020
SELL
$8.58 - $14.01 $284,890 - $465,188
-33,204 Reduced 39.35%
51,184 $516,000
Q4 2019

Feb 11, 2020
BUY
$8.22 - $14.0 $693,669 - $1.18 Million
84,388 New
84,388 $1.12 Million
Q1 2018

May 09, 2018
SELL
$11.13 - $13.63 $10,039 - $12,294
-902 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$12.07 - $14.87 $4,405 - $5,427
365 Added 67.97%
902 $14,000
Q2 2017

Aug 14, 2017
BUY
N/A
537
537 $10,000

Others Institutions Holding IRWD

# of Institutions
243
Shares Held
163M
Call Options Held
11.5M
Put Options Held
12.9K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $276M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email